Testimony before the Committee on Energy and Commerce, Subcommittee on Oversight and Investigations United States House of Representatives February 27, 2014 Elizabeth Jungman, Director, Drug Safety and Innovation The Pew

First Page		Document Content
Date: 2014-02-26 09:35:58 Pharmaceuticals policy Pharmacy Counterfeit consumer goods Clinical pharmacology Counterfeit medications Food and Drug Administration Medical prescription Serial number Pharmaceutical industry Pharmaceutical sciences Pharmacology Health		Testimony before the Committee on Energy and Commerce, Subcommittee on Oversight and Investigations United States House of Representatives February 27, 2014 Elizabeth Jungman, Director, Drug Safety and Innovation The Pew Add to Reading List Source URL: docs.house.gov Download Document from Source Website File Size: 318,42 KB Share Document on Facebook

	RETAIL PHARMACY CASE STUDY Retail Pharmacy and Healthcare Distributor Case Study Global powerhouse gains visibility, strategic power and clarity with KeyedIn Projects SaaS solution DocID: 1xVz3 - View Document
	Case Study: WESTERN MARYLAND PHARMACY Improving Clinical Outcomes and Decreasing Acetaminophen Costs by 78% with Diver Platform DocID: 1xTm3 - View Document
	PDF Document DocID: 1xQi5 - View Document
	PDF Document DocID: 1xNTr - View Document
	PDF Document DocID: 1xIyF - View Document